Medical News

RSS

Using oral blood pressure drug to treat Type 1 diabetes shows benefits for at least two years

Use of the drug verapamil to treat Type 1 diabetes continues to show benefits lasting at least two years, researchers report in the journal Nature Communications.

3 Mar 2022

People with high assets less likely to experience sustained depression during the pandemic

A new study found that individuals with physical, social, and financial assets, particularly higher incomes and fewer savings, were less likely to experience sustained depression during the first year of the pandemic.

3 Mar 2022

HPV-related cancers increase in U.S. counties with low-income, high smoking prevalence

A new paper in JNCI Cancer Spectrum, published by Oxford University Press, finds increases in both men and women for several HPV-related cancers in low-income counties or those with high smoking rates. Increases were slower in the highest-income US counties or those with low smoking rates.

3 Mar 2022

Study shows the impact of COVID-19 restrictions on dengue cases in 2020

Nearly three quarters of a million fewer global cases of dengue occurred in 2020, which could be linked to COVID-19 disruptions limiting human mobility and contact, according to a new study published in Lancet Infectious Diseases.

3 Mar 2022

Eating patterns may help explain different rates of heart disease, stroke among U.S. Hispanics/Latinos

Dietary patterns may help explain different rates of heart disease and stroke among various Hispanic/Latino populations in the U.S., according to preliminary research to be presented at the American Heart Association's Epidemiology, Prevention, Lifestyle & Cardiometabolic Health Conference 2022.

3 Mar 2022

Long or irregular menstrual cycles may be linked with increased risk of NAFLD

Women with long or irregular periods are known to have a higher risk of type 2 diabetes and heart disease, but researchers found these women may also be at risk for nonalcoholic fatty liver disease (NAFLD), according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology and Metabolism.

3 Mar 2022

KHN’s ‘What the Health?’: A health-heavy State of the Union

Russia's attacks on Ukraine took the headlines for President Joe Biden's first official State of the Union address, but Biden made a point to highlight several of the administration's high-priority health issues, including covid, mental health, nursing home regulation, and ailments among military personnel from toxic burn pits.

3 Mar 2022

Angiotensin-converting enzyme 2-based mutant decoy effectively reduces COVID-19 in mice

Researchers engineered a mutant ACE2 decoy that effectively protected human lung epithelia from SARS-CoV-2 infection by competitively binding to its spike protein.

3 Mar 2022

Clinical trial report endorses nitazoxanide as a safe drug for moderately ill COVID-19 patients

Researchers tested the safety and efficacy of 600 mg oral dose of nitazoxanide in mild or moderately ill COVID-19 patients.

3 Mar 2022

Convalescent plasma therapy shows no significant impact on COVID-19 recovery and outcomes

Researchers conduct a multi-center study involving hospitalized COVID-19 patients to gather information on the rationale use of convalescent plasma.

3 Mar 2022

Study provides insight into what causes therapy failure in patients with myelodysplastic syndromes

Researchers from The University of Texas MD Anderson Cancer Center discovered that treatment resistance in patients with myelodysplastic syndromes (MDS) is caused by two distinct classes of stem cells and identified possible therapeutic approaches that target these cells.

3 Mar 2022

8G3 broad-spectrum antibody effective against all SARS-CoV-2 variants, including Omicron

Researchers assess the efficacy of 8G3, a B-cell neutralizing antibody against SARS-CoV-2 variants, including the most recent Omicron variant.

3 Mar 2022

Incidence and outcomes of breakthrough SARS-CoV-2 infections in vaccinated chronic liver disease patients

A new study assesses breakthrough SARS-CoV-2 infections in vaccinated CLD patients with cirrhosis as compared to CLD patients without cirrhosis.

3 Mar 2022

Study shows targeting DDX3 with RK-33 reduced the viral load in four isolates of SARS-CoV-2

A new study has focused on developing a novel anti-SARS-CoV-2 therapy using HTA directed against the human host DEAD-box RNA helicase.

3 Mar 2022

Study establishes that a low dose SARS-CoV-2 infection increases risk of pneumococcal coinfection

A new study published on the bioRxiv* preprint server has evaluated bacterial susceptibility during SARS-CoV-2 infection.

3 Mar 2022

$The benefits of using fractional doses of COVID-19 vaccines$

Medical News

Using oral blood pressure drug to treat Type 1 diabetes shows benefits for at least two years

People with high assets less likely to experience sustained depression during the pandemic

HPV-related cancers increase in U.S. counties with low-income, high smoking prevalence

Study shows the impact of COVID-19 restrictions on dengue cases in 2020

Eating patterns may help explain different rates of heart disease, stroke among U.S. Hispanics/Latinos

Long or irregular menstrual cycles may be linked with increased risk of NAFLD

KHN’s ‘What the Health?’: A health-heavy State of the Union

Angiotensin-converting enzyme 2-based mutant decoy effectively reduces COVID-19 in mice

Clinical trial report endorses nitazoxanide as a safe drug for moderately ill COVID-19 patients

Convalescent plasma therapy shows no significant impact on COVID-19 recovery and outcomes

Study provides insight into what causes therapy failure in patients with myelodysplastic syndromes

8G3 broad-spectrum antibody effective against all SARS-CoV-2 variants, including Omicron

Incidence and outcomes of breakthrough SARS-CoV-2 infections in vaccinated chronic liver disease patients

Study shows targeting DDX3 with RK-33 reduced the viral load in four isolates of SARS-CoV-2

Study establishes that a low dose SARS-CoV-2 infection increases risk of pneumococcal coinfection

The benefits of using fractional doses of COVID-19 vaccines

First dose SARS-CoV-2 vaccination coverage among younger children in America

Infection with Omicron sub-lineage BA.1 protects from reinfection against BA.2 sub-lineage and vice-versa

Additional doses of covid-19 vaccine recommended for immunocompromised patients

Study explores coronavirus surveillance in bats from Argentina

How Programmable Nanobiology Could Drive the Fifth Industrial Revolution

Dr. Anthony Grice

Building quality into drug development for safer, faster medicines

Latest News